| 标题 |
Metabolomics and lipidomics predictor of survival in hepatocellular carcinoma patients receiving tyrosine kinase inhibitor and immune checkpoint inhibitor combination therapy |
| 网址 | |
| DOI | |
| 其它 |
期刊:Drug metabolism and disposition: the biological fate of chemicals 作者:Guan S; Yuan G; Xian T; Chen Y; Li R; et al 出版日期:2025/12/01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)